Natural history of chronic hepatitis B virus infection

Abstract Hepatitis B virus infection represents a major global health problem. Currently, there are more than 240 million chronically infected people worldwide. The development of chronic hepatitis B virus-mediated liver disease may lead to liver fibrosis, cirrhosis and eventually hepatocellular carcinoma. Recently, the discovery of the viral entry receptor sodium taurocholate cotransporting polypeptide has facilitated new approaches for a better understanding of viral physiopathology. Hopefully, these novel insights may give rise to the development of more effective antiviral therapy concepts during the next years. In this review, we will discuss the natural history of hepatitis B virus infection including the viral biology, the clinical course of infection and the role of the immune response.

[1]  A. Lok,et al.  Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005 , 2006, Hepatology.

[2]  B. Moss,et al.  The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis , 1995, The Journal of experimental medicine.

[3]  O. Pappo,et al.  Tracing hepatitis B virus to the 16th century in a Korean mummy , 2012, Hepatology.

[4]  Pratip K. Chattopadhyay,et al.  The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus Infection , 2009, Journal of Virology.

[5]  D. Vergani,et al.  Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms , 2000, Hepatology.

[6]  G. Fattovich,et al.  Epidemiology and natural history of hepatitis B , 2008 .

[7]  D. Hasenclever,et al.  Should Treatment of Hepatitis B Depend on Hepatitis B virus Genotypes? A Hypothesis Generated from an Explorative Analysis of Published Evidence , 2008, Antiviral Therapy.

[8]  A. Lok,et al.  Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. , 1987, Gastroenterology.

[9]  M. Çiriş,et al.  Cytokine levels and histopathology in chronic hepatitis B and chronic hepatitis C. , 2012, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[10]  J. Brosius,et al.  The genome of a Mesozoic paleovirus reveals the evolution of hepatitis B viruses , 2013, Nature Communications.

[11]  E John Wherry,et al.  T cell exhaustion , 2011 .

[12]  J. Pollack,et al.  Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis , 1994, Journal of virology.

[13]  I. Mushahwar,et al.  Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. , 1993, The Journal of general virology.

[14]  B. Moss,et al.  Live recombinant vaccinia virus protects chimpanzees against hepatitis B , 1984, Nature.

[15]  R. Sun,et al.  Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.

[16]  J. Summers,et al.  Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells , 1986, Cell.

[17]  J. Cullen,et al.  Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte , 1994, Journal of virology.

[18]  G. Alexander,et al.  Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection , 2008, The Journal of experimental medicine.

[19]  H. Varmus,et al.  Expression of the precore region of an avian hepatitis B virus is not required for viral replication , 1987, Journal of virology.

[20]  S. Urban,et al.  Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. , 2007, Hepatology.

[21]  Y. S. Hahn,et al.  Regulation of NK cell repertoire and function in the liver. , 2011, Critical reviews in immunology.

[22]  F. Miselli,et al.  Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. , 2004, Gastroenterology.

[23]  A. Boonstra,et al.  Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells , 2012, Journal of viral hepatitis.

[24]  P. Meier,et al.  Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. , 1994, The Journal of clinical investigation.

[25]  E. Sagnelli,et al.  Clinical impact of occult hepatitis B virus infection in immunosuppressed patients. , 2014, World journal of hepatology.

[26]  C. Seeger,et al.  Hepatitis B Virus Biology , 2000, Microbiology and Molecular Biology Reviews.

[27]  J. Hoofnagle,et al.  Management of hepatitis B: Summary of a clinical research workshop , 2007, Hepatology.

[28]  G. Michelone,et al.  Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. , 2009, Gastroenterology.

[29]  M. Maini,et al.  Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection , 2010, PLoS pathogens.

[30]  M. Fälth,et al.  Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. , 2014, Gastroenterology.

[31]  B. McMahon,et al.  The Natural History of Chronic Hepatitis B Virus Infection , 2004, Seminars in liver disease.

[32]  C. Chu,et al.  Precore Stop Mutant in HBeAg-Positive Patients with Chronic Hepatitis B: Clinical Characteristics and Correlation with the Course of HBeAg-to-Anti-HBe Seroconversion , 2002, Journal of Clinical Microbiology.

[33]  P. Coursaget,et al.  Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes , 2004, Intervirology.

[34]  E. Christensen,et al.  Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type B , 1995, Hepatology.

[35]  M. Dandri,et al.  The replication cycle of hepatitis B virus. , 2010, Journal of hepatology.

[36]  M. Smyth,et al.  Functional interactions between dendritic cells and NK cells during viral infection , 2003, Nature Immunology.

[37]  D. Milich,et al.  Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection , 2003, Hepatology.

[38]  R. Thimme,et al.  Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. , 2014, Journal of hepatology.

[39]  R. Pierce,et al.  TLR-dependent cross talk between human Kupffer cells and NK cells , 2008, The Journal of experimental medicine.

[40]  A. Bertoletti,et al.  Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection , 2011, Postgraduate Medical Journal.

[41]  M. Imai,et al.  Immunochemical structure of hepatitis B e antigen in the serum. , 1983, Journal of immunology.

[42]  M. Lai,et al.  Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. , 1997, The New England journal of medicine.

[43]  D. Ganem,et al.  Assembly of hepadnaviral virions and subviral particles. , 1991, Current topics in microbiology and immunology.

[44]  L. Ye,et al.  Pathogenesis of hepatitis B virus infection , 2006 .

[45]  P. Meier,et al.  In situ localization of the hepatocytic Na+/Taurocholate cotransporting polypeptide in rat liver. , 1994, Gastroenterology.

[46]  S. Ho,et al.  Dating the origin and dispersal of hepatitis B virus infection in humans and primates , 2013, Hepatology.

[47]  S. Yuen,et al.  Natural history and disease progression in Chinese chronic hepatitis B patients in immune‐tolerant phase , 2007, Hepatology.

[48]  G. Freeman,et al.  PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status , 2007, AIDS.

[49]  S. Locarnini,et al.  Possible origins and evolution of the hepatitis B virus (HBV). , 2013, Seminars in cancer biology.

[50]  Conn Nk,et al.  Letter: Avirulent corynebacteria. , 1975 .

[51]  B. McMahon,et al.  Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus , 2001, Annals of Internal Medicine.

[52]  T. Mak,et al.  Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity , 2011, Proceedings of the National Academy of Sciences.

[53]  R. Gish,et al.  HBV core sequence: definition of genotype‐specific variability and correlation with geographical origin , 2004, Journal of viral hepatitis.

[54]  M. Buendia,et al.  Statements from the Taormina expert meeting on occult hepatitis B virus infection. , 2008, Journal of hepatology.

[55]  G. Reynolds,et al.  Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion , 2013, The Journal of experimental medicine.

[56]  B. Stieger.  The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. , 2011, Handbook of experimental pharmacology.

[57]  L. Teyton,et al.  Interleukin-10 determines viral clearance or persistence in vivo , 2006, Nature Medicine.

[58]  R. Welsh,et al.  Natural killer cells act as rheostats modulating antiviral T cells , 2011, Nature.

[59]  W. Gerlich,et al.  Occult Hepatitis B Virus Infection: Detection and Significance , 2010, Digestive Diseases.

[60]  G. Raimondo,et al.  Occult hepatitis B infection. , 2014, Journal of hepatology.

[61]  F. Chisari,et al.  Immune effectors required for hepatitis B virus clearance , 2009, Proceedings of the National Academy of Sciences.

[62]  D. S. Dane,et al.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. , 1970, Lancet.

[63]  F Tsuda,et al.  Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen , 1990, Journal of virology.

[64]  M. Kann,et al.  Intracellular transport of hepatitis B virus. , 2007, World journal of gastroenterology.

[65]  R. Purcell,et al.  The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host , 1992, Journal of virology.

[66]  P. Klenerman,et al.  Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. , 2009, Gastroenterology.

[67]  B. Hartmann,et al.  Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection. , 1999, Virology.

[68]  R. Purcell,et al.  Genomic analysis of the host response to hepatitis B virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[69]  H. Hsu,et al.  Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. , 1996, JAMA.

[70]  H. Blum,et al.  HBV life cycle and novel drug targets , 2011, Hepatology international.

[71]  F. Zoulim,et al.  Woodchuck hepatitis virus X protein is required for viral infection in vivo , 1994, Journal of virology.

[72]  C. Hourioux,et al.  Morphogenesis of hepatitis B virus and its subviral envelope particles , 2009, Cellular microbiology.

[73]  Ruy M Ribeiro,et al.  Dynamics of hepatitis B virus infection. , 2002, Microbes and infection.

[74]  C. Feschotte,et al.  Genomic Fossils Calibrate the Long-Term Evolution of Hepadnaviruses , 2010, PLoS biology.

[75]  E. Wherry,et al.  IL-10, T cell exhaustion and viral persistence. , 2007, Trends in microbiology.

[76]  L. Peyrin-Biroulet,et al.  [Epidemiology and natural history of hepatitis C]. , 2005, La Revue du praticien.

[77]  D. Ganem,et al.  Hepatitis B virus infection--natural history and clinical consequences. , 2004, The New England journal of medicine.

[78]  R. Beasley.  Hepatitis B virus. The major etiology of hepatocellular carcinoma , 1988, Cancer.

[79]  M. Maini,et al.  NK Cells: A Double-Edged Sword in Chronic Hepatitis B Virus Infection , 2013, Front. Immunol..

[80]  Geoffrey Dusheiko,et al.  Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy , 2004, Journal of Virology.

[81]  W. Haining,et al.  Resolution of a chronic viral infection after interleukin-10 receptor blockade , 2006, The Journal of experimental medicine.

[82]  Wenhui Li,et al.  Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus , 2012, eLife.

[83]  Michael G Brown,et al.  Intrahepatic IL-10 Maintains NKG2A+Ly49− Liver NK Cells in a Functionally Hyporesponsive State , 2010, The Journal of Immunology.

[84]  R. Purcell,et al.  CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.

[85]  H. Janssen,et al.  Treatment with Peg-Interferon α-2b for HBeAg-Positive Chronic Hepatitis B: HBsAg Loss Is Associated with HBV Genotype , 2006, The American Journal of Gastroenterology.

[86]  A Valli,et al.  Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. , 1990, Journal of immunology.

[87]  O. Shibolet,et al.  Immunosuppression and HBV Reactivation , 2013, Seminars in Liver Disease.